Galera Therapeutics, Inc. (GRTX) Net Cash Provided by (Used in) Financing Activities USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Galera Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Galera Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Galera Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $31.5 M, a 710% increase from 2022.
  • Galera Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.89 M, a 94.2% decline from 2021.
  • Galera Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $66.7 M, a 225% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $31.5 M +$27.6 M +710% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $3.89 M -$62.8 M -94.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $66.7 M +$46.2 M +225% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $20.5 M -$57.5 M -73.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $78 M -$11.8 M -13.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $89.8 M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.